NUE
58
7
DRI
48
3
SWK
61
5
CMS
60
2
NRG
52
3
HRL
41
2
ZTS
49
2
CRM
65
6
GPC
37
2
VRSN
57
4
SWKS
49
11
DE
56
10
TRV
56
3
EQR
59
5
GWW
71
4
AZO
48
2
EXR
60
3
FITB
60
2
MS
76
2
AKAM
50
7
NUE
58
7
DRI
48
3
SWK
61
5
CMS
60
2
NRG
52
3
HRL
41
2
ZTS
49
2
CRM
65
6
GPC
37
2
VRSN
57
4
SWKS
49
11
DE
56
10
TRV
56
3
EQR
59
5
GWW
71
4
AZO
48
2
EXR
60
3
FITB
60
2
MS
76
2
AKAM
50
7
Financhill
Back

Catalyst Pharmaceuticals Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
46

CPRX
Catalyst Pharmaceuticals

Last Price:
21.46
Seasonality Move:
4.48%
Sell
30

SRPT
Sarepta Therapeutics

Last Price:
114.27
Seasonality Move:
16.38%
Sell
46
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $21.12. The Score for CPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $110.50. The Score for SRPT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $21.12
    The current trend is relatively stagnant and CPRX is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $110.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 45.27 Sell
Chaikin Money Flow: 380001 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.02 - 22.7) Sell
Bollinger Bands (100): (17.53 - 21.69) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.89 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 63193 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112 - 129.78) Sell
Bollinger Bands (100): (119.81 - 143.67) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.58 Sell
20-day SMA: 22 Sell
50-day SMA: 21.09 Buy
200-day SMA: 17.53 Buy
8-day EMA: 21.5 Sell
20-day EMA: 21.69 Sell
50-day EMA: 21.05 Buy
200-day EMA: 18.22 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.13 Buy
20-day SMA: 118.88 Sell
50-day SMA: 122.22 Sell
200-day SMA: 130.09 Sell
8-day EMA: 110.76 Sell
20-day EMA: 116.02 Sell
50-day EMA: 122.15 Sell
200-day EMA: 126.16 Sell

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.72 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):